Showing results (2191-2200 of 2,727) with videos related to
Sort By:
Pageof 273
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Evaluation of 11C-NR2B-SMe and Its Enantiomers as PET Radioligands for Imaging the NR2B Subunit Within the NMDA Receptor Complex in RatsLisheng Cai, Jeih-San Liow, Cheryl L Morse, et al.Human Vaccines|October 3, 2006
Comparison of rabbit and mouse models for persistence analysis of plasmid-based vaccinesVicky L Leamy, Terrie Martin, Rohit Mahajan, et al.British Journal of Cancer|August 12, 2004
Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III studyG D Hall, J M Brown, R E Coleman, et al.American Journal of Mental Retardation : AJMR|March 6, 2004
Aging in individuals with the FMR1 mutationS Jacquemont, F Farzin, D Hall, et al.Neuroimage|November 6, 2004
A general linear model for MEG beamformer imagingMatthew J Brookes, Andrew M Gibson, Stephen D Hall, et al.Journal of Speech, Language, and Hearing Research : JSLHR|April 7, 2017
A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: IntroductionLawrence D Shriberg, Edythe A Strand, Marios Fourakis, et al.Journal of Speech, Language, and Hearing Research : JSLHR|April 7, 2017
A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: I. Development and Description of the Pause MarkerLawrence D Shriberg, Edythe A Strand, Marios Fourakis, et al.Journal of Speech, Language, and Hearing Research : JSLHR|April 7, 2017
A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: II. Validity Studies of the Pause MarkerLawrence D Shriberg, Edythe A Strand, Marios Fourakis, et al.AIDS (London, England)|October 9, 1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyJ M Raboud, J S Montaner, B Conway, et al.ACS Medicinal Chemistry Letters|August 16, 2021
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike ProteinXin Hu, Catherine Z Chen, Miao Xu, et al.Pageof 273